HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor (full – 1999) http://www.ncbi.nlm.nih.gov/pmc/arti...9/?tool=pubmed
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation (full – 2005)http://www.fasebj.org/cgi/content/fu...urcetype=HWCIT
Peripheral cannabinoid receptor, CB2, regulates bone mass (full – 2005) http://www.pnas.org/content/103/3/696.full
Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain (abst - 2005)http://www.ncbi.nlm.nih.gov/pubmed/16316653
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation (full – 2006)http://www.fasebj.org/content/20/13/2405.long
Activation of CB2 receptor attenuates bone loss in osteoporosis (news – 2006) http://www.cannabis-med.org/english/...l.php?id=210#2
Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis (full - 2007) http://www.jleukbio.org/cgi/content/full/82/6/1382
Endocannabinoids, cannabinoid receptors and inflammatory stress: an interview with Dr. Pál Pacher (interview – 2007)http://www.jleukbio.org/cgi/content/...urcetype=HWCIT
Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor (full – 2008)http://press.endocrine.org/doi/full/...0/en.2008-0150
Gadolinium-HU-308-incorporated micelles (full – 2011) http://www.ncbi.nlm.nih.gov/books/NB...d-Micelles.pdf
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
The Type 2 Cannabinoid Receptor Regulates Bone Mass and Ovariectomy-Induced Bone Loss by Affecting Osteoblast Differentiation and Bone Formation (full – 2011) http://press.endocrine.org/doi/full/...0/en.2010-0930
CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling (full – 2011)http://www.jbc.org/content/287/2/1198.full
Cannabinoid-2 Receptor Activation Protects against Infarct and Ischemia/Reperfusion Heart Injury (abst – 2011)http://www.ncbi.nlm.nih.gov/pubmed/22113346
Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis (full – 2012) http://ccforum.com/content/16/2/R47
Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB(1) receptor-mediated anti-inflammatory effects (abst - 2012) http://www.ncbi.nlm.nih.gov/pubmed/22342378
Effect of omega-3 polyunsaturated fatty acids on the endocannabinoid system in osteoblast-like cells and muscle (abst – 2012)http://docs.lib.purdue.edu/dissertations/AAI3444794/
Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23908133
Prospects for cannabinoid therapies in viral encephalitis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24021420
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis (full – 2014) http://www.hindawi.com/journals/mi/2014/978678/
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective (full– 2014)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24440992
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst – 2014)http://onlinelibrary.wiley.com/doi/1...23452/abstract
Protection from osteoarthritis may lie in our own joints, study suggests (news – 2014) http://www.alphagalileo.org/ViewItem...CultureCode=en
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation (full – 2005)http://www.fasebj.org/cgi/content/fu...urcetype=HWCIT
Peripheral cannabinoid receptor, CB2, regulates bone mass (full – 2005) http://www.pnas.org/content/103/3/696.full
Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain (abst - 2005)http://www.ncbi.nlm.nih.gov/pubmed/16316653
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation (full – 2006)http://www.fasebj.org/content/20/13/2405.long
Activation of CB2 receptor attenuates bone loss in osteoporosis (news – 2006) http://www.cannabis-med.org/english/...l.php?id=210#2
Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis (full - 2007) http://www.jleukbio.org/cgi/content/full/82/6/1382
Endocannabinoids, cannabinoid receptors and inflammatory stress: an interview with Dr. Pál Pacher (interview – 2007)http://www.jleukbio.org/cgi/content/...urcetype=HWCIT
Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor (full – 2008)http://press.endocrine.org/doi/full/...0/en.2008-0150
Gadolinium-HU-308-incorporated micelles (full – 2011) http://www.ncbi.nlm.nih.gov/books/NB...d-Micelles.pdf
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
The Type 2 Cannabinoid Receptor Regulates Bone Mass and Ovariectomy-Induced Bone Loss by Affecting Osteoblast Differentiation and Bone Formation (full – 2011) http://press.endocrine.org/doi/full/...0/en.2010-0930
CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling (full – 2011)http://www.jbc.org/content/287/2/1198.full
Cannabinoid-2 Receptor Activation Protects against Infarct and Ischemia/Reperfusion Heart Injury (abst – 2011)http://www.ncbi.nlm.nih.gov/pubmed/22113346
Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis (full – 2012) http://ccforum.com/content/16/2/R47
Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB(1) receptor-mediated anti-inflammatory effects (abst - 2012) http://www.ncbi.nlm.nih.gov/pubmed/22342378
Effect of omega-3 polyunsaturated fatty acids on the endocannabinoid system in osteoblast-like cells and muscle (abst – 2012)http://docs.lib.purdue.edu/dissertations/AAI3444794/
Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23908133
Prospects for cannabinoid therapies in viral encephalitis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24021420
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis (full – 2014) http://www.hindawi.com/journals/mi/2014/978678/
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective (full– 2014)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24440992
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst – 2014)http://onlinelibrary.wiley.com/doi/1...23452/abstract
Protection from osteoarthritis may lie in our own joints, study suggests (news – 2014) http://www.alphagalileo.org/ViewItem...CultureCode=en